Sort
25,944 grants matching “neurodegeneration”
Molecular Mechanisms of HIV-1 Associated Encephalopathy
$1,487,483St. Luke'S-Roosevelt Inst For Hlth Scis · P01 · FY2004 · NS
Mitochondrial transport: impact on synaptic transmission and neurodegeneration
$1,486,756Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Plasma brain-derived tau: a novel Alzheimerâs disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood
$1,483,998Thomas K Karikari · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AG
A dual-source ion mobility mass spectrometry system
$1,481,999Stephanie M Cologna · University Of Illinois At Chicago · S10 · FY2025 · OD
A resource for magnetic resonance and optical imaging
$1,481,535Ravinder Reddy · University Of Pennsylvania · P41 · FY2013 · EB
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways
$1,481,400Matthew D Disney · Scripps Florida · P01 · FY2017 · NS
Axonal transport regulates synaptic function and axonal homeostasis
$1,481,120Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Development of a PIKFYVE antisense oligonucleotide treatment for FTD
$1,480,550Samuel V Alworth · Acurastem, Inc. · R44 · FY2022 · NS
A Caribbean Project for Clinical and Basic Neuroscience Research
$1,479,021Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · U54 · FY2008 · NS
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP
$1,477,591Thomas C Neylan · University Of California, San Francisco · R01 · FY2024 · AG
Genetic models of sporadic Alzheimers Disease in the marmoset
$1,476,351Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2023 · AG
alpha-Synuclein and LRRK2 in the Pathogenesis of Parkinson's Disease
$1,475,093Jie Shen · Brigham And Women'S Hospital · P50 · FY2015 · NS
DETECT-AD: Digital Evaluations and Technologies Enabling Clinical Translation for Alzheimer's Disease
$1,474,986Jeffrey A Kaye · Oregon Health & Science University · R56 · FY2021 · AG
CENTER FOR STRUCTURAL AND FUNCTIONAL NEUROSCIENCE
$1,471,394University Of Montana · P20 · FY2003 · RR
CENTER FOR STRUCTURAL AND FUNCTIONAL NEUROSCIENCE
$1,471,209University Of Montana · P20 · FY2000 · RR
Cyclin-dependent kinase 5 (Cdk5 physiology and pathology)
$1,470,319Harish C Pant · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
Detection of Prions
$1,470,276Byron Caughey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
TimsTOF-fleX MALDI-2 mass-spectrometer
$1,469,740Rinat Abzalimov · Advanced Science Research Center · S10 · FY2024 · OD
Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD
$1,468,850Linda J Van Eldik · University Of Kentucky · U01 · FY2017 · AG
Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD
$1,468,541Sean Reineke · Aromha, Inc. · R42 · FY2022 · AG
An acquisition and analysis pipeline for integrating MRI and neuropathology in TBI-related dementia and VCID
$1,466,860Andre Jan Willem Van Der Kouwe · Massachusetts General Hospital · U24 · FY2023 · NS
Regional, Synaptic, Cellular Modulation of Abeta Metabolism
$1,466,153David M Holtzman · Washington University · P01 · FY2019 · NS
Mu Center for Botanical Interaction Studies
$1,465,935Dennis B Lubahn · University Of Missouri-Columbia · P50 · FY2012 · AT
Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-alpha1 in Neural and Cognitive Functions
$1,464,090Yoke Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Higher Order Chromatin and Genetic Risk for Alzheimer's Disease
$1,463,214Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG